Suchergebnisse - (Subject:"Adalimumab")

PubPharm (21)

1

Biological therapy of uveitis in children

enthalten in: Orvosi hetilap | 2022

von Smeller, L. | Sümegi, V. | Tóth-Molnár, E. | +1

2

Ophthalmic use of TNFα inhibitor : adalimumab treatment in uveitis

enthalten in: Orvosi hetilap | 2021

von Géhl, Z. | Szepessy, Z. | Nagy, Z.

3

Long-term follow-up of inflammatory bowel disease patients receiving anti-tumor necrosis factor-alpha therapy

enthalten in: Orvosi hetilap | 2020

von Bacsur, P. | Skribanek, S. | Milassin, �. | +11

4

Systemic biological treatment in ophthalmology

enthalten in: Orvosi hetilap | 2019

von Benyó, F. | Farkas, A. | Horváth, H. | +2

5

Clinical features and therapy of uveitis in childhood

enthalten in: Orvosi hetilap | 2019

von Kiss, J. | Gaál, V. | Nyul, Z. | +1

6

Long-term adalimumab therapy in ulcerative colitis in clinical practice : result of the Hungarian multicenter prospective study

enthalten in: Orvosi hetilap | 2016

von Rutka, M. | Bálint, A. | Farkas, K. | +19

7

Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease

enthalten in: Orvosi hetilap | 2013

von Bor, R. | Farkas, K. | Bálint, A. | +7

8

Epidemiology, predictors and clinical aspects of loss of response to biological therapy

enthalten in: Orvosi hetilap | 2012

von Lorinczy, K. | Miheller, P. | Kiss, S. | +1

9

Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary

enthalten in: Orvosi hetilap | 2011

von Kiss, L. | Szamosi, T. | Molnár, T. | +21

10

Frequency and possible reasons for the loss of response to biological therapy in Crohn's disease after a one-year treatment period

enthalten in: Orvosi hetilap | 2011

von Molnár, T. | Farkas, K. | Nyári, T. | +4